338 related articles for article (PubMed ID: 31015585)
1. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.
Chang CL; Huang SY; Hsu YC; Chin TH; Soong YK
Sci Rep; 2019 Apr; 9(1):6447. PubMed ID: 31015585
[TBL] [Abstract][Full Text] [Related]
2. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
[TBL] [Abstract][Full Text] [Related]
3. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Alan M; Gurlek B; Yilmaz A; Aksit M; Aslanipour B; Gulhan I; Mehmet C; Taner CE
Gynecol Endocrinol; 2019 Mar; 35(3):220-223. PubMed ID: 30325247
[TBL] [Abstract][Full Text] [Related]
4. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
5. Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study.
Jiang Y; Liu Y; Yu Z; Yang P; Zhao S
Rev Assoc Med Bras (1992); 2021 Apr; 67(4):590-596. PubMed ID: 34495066
[TBL] [Abstract][Full Text] [Related]
6. Serum irisin concentrations in lean adolescents with polycystic ovary syndrome.
Bacopoulou F; Athanasopoulos N; Efthymiou V; Mantzou A; Aravantinos L; Vlahopoulos S; Deligeoroglou E
Clin Endocrinol (Oxf); 2018 Apr; 88(4):585-591. PubMed ID: 29368340
[TBL] [Abstract][Full Text] [Related]
7. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
8. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
9. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
[TBL] [Abstract][Full Text] [Related]
10. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome.
Deniz R; Yavuzkir S; Ugur K; Ustebay DU; Baykus Y; Ustebay S; Aydin S
J Obstet Gynaecol; 2021 Feb; 41(2):279-284. PubMed ID: 32608281
[TBL] [Abstract][Full Text] [Related]
11. Serum irisin levels in polycystic ovary syndrome after ovarian drilling.
Foda AA; Foda EA; El-Said ZH
Diabetes Metab Syndr; 2019; 13(2):1463-1468. PubMed ID: 31336507
[TBL] [Abstract][Full Text] [Related]
12. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients.
Wang W; Guo Y; Zhang X; Zheng J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):474-480. PubMed ID: 29972694
[TBL] [Abstract][Full Text] [Related]
13. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
15. Serum irisin levels in patients with polycystic ovary syndrome.
Bostancı MS; Akdemir N; Cinemre B; Cevrioglu AS; Özden S; Ünal O
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4462-8. PubMed ID: 26698239
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
17. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
[TBL] [Abstract][Full Text] [Related]
18. Effect of Metformin Treatment on Insulin Resistance Markers, and Circulating Irisin in Women with Polycystic Ovarian Syndrome (PCOS).
Masaeli A; Nayeri H; Mirzaee M
Horm Metab Res; 2019 Sep; 51(9):575-579. PubMed ID: 31121610
[TBL] [Abstract][Full Text] [Related]
19. Higher circulating irisin levels in patients with polycystic ovary syndrome:a meta-analysis.
Wang C; Zhang XY; Sun Y; Hou XG; Chen L
Gynecol Endocrinol; 2018 Apr; 34(4):290-293. PubMed ID: 29069945
[TBL] [Abstract][Full Text] [Related]
20. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome.
Cao S; Hu Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34427289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]